Market Maelstrom: A Perfect Storm of Setbacks and Uncertainty The UK's business landscape is facing a triple threat of setbacks, each one more alarming than the last.
According to the latest survey from the Royal Institution of Chartered Surveyors (RICS), the housing market remains "fragile" despite a slight easing of downturn.
GSK's decision to sever ties with Alector is particularly noteworthy. The collapse of latozinemab and nivisnebart trials marks yet another high profile failure in neurodegenerative diseases.